Camlin Fine Sciences Limited (CAMLINFINE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Camlin Fine Sciences Limited (CAMLINFINE) has a cash flow conversion efficiency ratio of 0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs671.39 Million ≈ $7.26 Million USD) by net assets (Rs8.60 Billion ≈ $93.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Camlin Fine Sciences Limited (CAMLINFINE) market capitalisation for the company's overall valuation and market capitalisation.
Camlin Fine Sciences Limited - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Camlin Fine Sciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Camlin Fine Sciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Camlin Fine Sciences Limited ranked by their cash flow conversion efficiency. Explore CAMLINFINE cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nova Lifestyle I
NASDAQ:NVFY
|
-0.140x |
|
Adgar Investments and Development Ltd
TA:ADGR
|
0.019x |
|
Eledon Pharmaceuticals Inc
NASDAQ:ELDN
|
-0.103x |
|
Brogent Technologies
TWO:5263
|
0.036x |
|
Hester Biosciences Limited
NSE:HESTERBIO
|
0.050x |
|
Skue Sparebank
OL:SKUE
|
0.056x |
|
Jin Air Co Ltd
KO:272450
|
-0.104x |
|
ST.GEORGE MINING LTD
F:S0G
|
N/A |
Annual Cash Flow Conversion Efficiency for Camlin Fine Sciences Limited (2007–2025)
The table below shows the annual cash flow conversion efficiency of Camlin Fine Sciences Limited from 2007 to 2025. View Camlin Fine Sciences Limited (CAMLINFINE) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs8.75 Billion ≈ $94.60 Million |
Rs267.23 Million ≈ $2.89 Million |
0.031x | -81.16% |
| 2024-03-31 | Rs8.57 Billion ≈ $92.68 Million |
Rs1.39 Billion ≈ $15.03 Million |
0.162x | +162.59% |
| 2023-03-31 | Rs8.24 Billion ≈ $89.12 Million |
Rs508.98 Million ≈ $5.50 Million |
0.062x | -67.51% |
| 2022-03-31 | Rs7.65 Billion ≈ $82.74 Million |
Rs1.45 Billion ≈ $15.73 Million |
0.190x | +15.50% |
| 2021-03-31 | Rs7.13 Billion ≈ $77.12 Million |
Rs1.17 Billion ≈ $12.69 Million |
0.165x | -11.96% |
| 2020-03-31 | Rs4.60 Billion ≈ $49.76 Million |
Rs860.20 Million ≈ $9.30 Million |
0.187x | +994.14% |
| 2019-03-31 | Rs4.30 Billion ≈ $46.53 Million |
Rs-89.97 Million ≈ $-972.97K |
-0.021x | +41.19% |
| 2018-03-31 | Rs4.33 Billion ≈ $46.87 Million |
Rs-154.09 Million ≈ $-1.67 Million |
-0.036x | +5.85% |
| 2017-03-31 | Rs2.30 Billion ≈ $24.89 Million |
Rs-86.93 Million ≈ $-940.15K |
-0.038x | -109.30% |
| 2016-03-31 | Rs1.76 Billion ≈ $19.06 Million |
Rs715.72 Million ≈ $7.74 Million |
0.406x | +18.42% |
| 2015-03-31 | Rs1.35 Billion ≈ $14.59 Million |
Rs462.55 Million ≈ $5.00 Million |
0.343x | +19.66% |
| 2014-03-31 | Rs933.04 Million ≈ $10.09 Million |
Rs267.42 Million ≈ $2.89 Million |
0.287x | -66.30% |
| 2013-03-31 | Rs653.83 Million ≈ $7.07 Million |
Rs556.14 Million ≈ $6.01 Million |
0.851x | +241.22% |
| 2012-03-31 | Rs529.06 Million ≈ $5.72 Million |
Rs-318.65 Million ≈ $-3.45 Million |
-0.602x | -769.37% |
| 2011-03-31 | Rs464.53 Million ≈ $5.02 Million |
Rs41.80 Million ≈ $452.03K |
0.090x | +142.33% |
| 2010-03-31 | Rs291.32 Million ≈ $3.15 Million |
Rs10.82 Million ≈ $116.98K |
0.037x | -77.42% |
| 2009-03-31 | Rs291.41 Million ≈ $3.15 Million |
Rs47.91 Million ≈ $518.17K |
0.164x | +20.49% |
| 2008-03-31 | Rs278.32 Million ≈ $3.01 Million |
Rs37.98 Million ≈ $410.72K |
0.136x | -78.93% |
| 2007-03-31 | Rs199.57 Million ≈ $2.16 Million |
Rs129.28 Million ≈ $1.40 Million |
0.648x | -- |
About Camlin Fine Sciences Limited
Camlin Fine Sciences Limited, together with its subsidiaries, research, develops, manufactures, and markets specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include basic ingredients, such as tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), and Ascorbyl Palmitate… Read more